Peyramond D, Denoyel G A, Philip T, Souillet G, Philippe N, Bertrand J L, Bertoye A
Arch Fr Pediatr. 1983 Feb;40(2):95-9.
Sixty minutes intravenous infusions of Acyclovir were given at 5 to 10 mg/kg 3 times daily for 6 to 11 days in 20 immunodeficient children with varicella (9 cases) and herpes zoster (11 cases) in a controlled open study. Twelve patients had a life-threatening illness. All patients who received therapy before the first 4 days had a more rapid cessation of new vesicles formation and more rapid scarring. Fourteen controlled children had accelerated clearance of viral antigens from vesicles. In 19 cases, virus was no longer isolated after the 3rd day. Eighteen patients recovered within 6 to 10 days. No relapse of varicella zoster virus infections had been observed 1 to 18 months after the end of treatment. Two children with varicellous interstitial pneumonia died 8 and 32 days after the end of treatment. In 3 cases, zoster pains reappeared 8 days after Acyclovir therapy was stopped. The drug was well-tolerated, but control of renal functions is necessary.
在一项开放性对照研究中,对20名患有水痘(9例)和带状疱疹(11例)的免疫缺陷儿童,给予阿昔洛韦以5至10mg/kg的剂量进行60分钟静脉输注,每日3次,持续6至11天。12名患者患有危及生命的疾病。所有在最初4天内接受治疗的患者,新水疱形成停止得更快,结痂也更快。14名对照儿童水疱中的病毒抗原清除加快。19例在第3天后不再分离出病毒。18名患者在6至10天内康复。治疗结束后1至18个月未观察到水痘带状疱疹病毒感染复发。两名患有水痘间质性肺炎的儿童在治疗结束后8天和32天死亡。3例在阿昔洛韦治疗停止8天后带状疱疹疼痛再次出现。该药物耐受性良好,但有必要监测肾功能。